Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Corticosteroid and Cyclosporine-A for COVID-19 Keratoconjunctivitis
NCT04451239Unknown
- Start
- Jun 2020
- Primary completion
- Jul 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of prednisolone and CyclAGel in Keratoconjunctivitis (KC). Primary endpoints: Symptom improvement and Signs improvement. Status: unknown.
02
Drugs
prednisoloneCyclAGel
03
Conditions
Keratoconjunctivitis (KC)
Beyond the preview
Go deeper on NCT04451239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04451239.